OTC Healthcare in Mexico
Euromonitor International's OTC Healthcare in Mexico market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 109 | Publication date: Feb 2008
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Generics affect the dynamism of OTC healthcare sales
OTC healthcare is highly competitive and became more so with the recent emergence of generics, through Farmacias de Similares, a chain of pharmacies that manufactures similares or generic versions of brands. The government exerts some control over these players. However, legislation is still vague and the effect that this competition is having on OTC healthcare is notable. In addition, the ease with which most people can buy under-the-counter drugs puts OTC healthcare in a very difficult situation.
Seguro Popular influencing OTC healthcare
Pharmaceutical sales became more complex since the approval of Seguro Popular, a public policy that provides low-cost medical services to people currently excluded from government-provided healthcare. The Seguro Popular initiative targets close to half of the Mexican population. One aspect of this service is that both prescription and OTC healthcare provided through the initiative is generic, rather than branded. Domestic manufacturers generally supply generics to the government, rather than the multinationals that dominate OTC healthcare in Mexico.
Pharmaceutical players struggle to maintain share
Many factors affected the local pharmaceutical industry, particularly the introduction of generics. The large laboratories are suffering from competition from generics, particularly via Farmacias Similares. A large quantity of generics was offered at low prices by the government through social programmes. Consequently, OTC healthcare lost competitiveness and price reductions were inevitable.
Success is based on lobbying doctors
Since the mass media advertising of OTC healthcare is restricted by the government, players compete through an extensive sales force. Success depends primarily on their ability to win the support of doctors and pharmacy owners. While brand loyalty is high, it generally develops as the result of an initial recommendation from a doctor or pharmacist.
Socio-economic trends favour OTC healthcare over the forecast period
Despite the negative performance of branded OTC healthcare in 2006, prospects point towards a recovery during the forecast period. The general economic situation, with a middle-income group improving their purchasing power and a gradually aging population, will affect sales positively. More people will be able to afford branded OTC healthcare in the near future. In addition, responsible self-medication is projected to increase for niche OTC healthcare, as firms invest in growing sales through educational campaigns. Overall, the negative effect of generics on value sales will be offset in most product areas by an increase in demand. This will be driven either by consumers switching from traditional remedies to OTC healthcare or by changing environmental and demographic trends.
Table of contents
OTC HEALTHCARE IN MEXICO : MARKET INSIGHT
EXECUTIVE SUMMARY
Pharmaceutical players struggle to maintain share
Success is based on lobbying doctors
Socio-economic trends favour OTC healthcare over the forecast period
KEY TRENDS AND DEVELOPMENTS
Seguro Popular promises health coverage for the neglected
Generics face an uphill battle
Farmacias Similares remains strong
Socio-economic trends favour OTC healthcare
OTC sales expand along with retail growth
MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Penetration of Private Label by Sector 2002-2006
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification
Vitamins and dietary supplements registration and classification
Generics
Consumer expenditure on health goods and medical services
Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
LOCAL COMPANY PROFILES - MEXICO
BAYER DE MéXICO SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Bayer de México SA de CV: Key Facts
Summary 3 Bayer de México SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 4 Bayer de México SA de CV: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 5 Bayer de México SA de CV: Competitive Position 2006
BOEHRINGER INGELHEIM PROMECO SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Boehringer Ingelheim Promeco SA de CV: Key Facts
Summary 7 Boehringer Ingelheim Promeco SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 8 Boehringer Ingelheim Promeco SA de CV: Competitive Position 2006
GLAXOSMITHKLINE MéXICO SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 9 GlaxoSmithKline México SA de CV: Key Facts
Summary 10 GlaxoSmithKline México SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 11 Summary GlaxoSmithKline México SA de CV: Competitive Position 2006
LABORATORIOS LIOMONT SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 12 Laboratorios Liomont SA de CV: Key Facts
Summary 13 Laboratorios Liomont SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 14 Laboratorios Liomont SA de CV: Production Statistics 2006
Summary 15 Laboratorios Liomont SA de CV: Production Capacity by Format
COMPETITIVE POSITIONING
Summary 16 Summary Laboratorios Liomont SA de CV: Competitive Position 2006
MERCK-MéXICO SA - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 17 Merck-México SA: Key Facts
Summary 18 Merck-México SA: Operational Indicators
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 19 Merck-México SA: Competitive Position 2006
NOVARTIS FARMACéUTICA SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 20 Novartis Farmacéutica SA de CV: Key Facts
Summary 21 Novartis Farmacéutica SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 22 Novartis Farmacéutica SA de CV: Competitive Position 2006
PFIZER SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 23 Pfizer SA de CV: Key Facts
Summary 24 Pfizer SA de CV: Operational Indicators
COMPANY BACKGROUND
COMPETITIVE POSITIONING
Summary 25 Pfizer SA de CV: Competitive Position 2006
PROCTER & GAMBLE DE MéXICO SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 26 Procter & Gamble de México SA de CV Key Facts
Summary 27 Procter & Gamble de México SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 28 Procter & Gamble de México SA de CV: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 29 Procter & Gamble de México SA de CV: Competitive Position 2006
WYETH SA DE CV - OTC HEALTHCARE - MEXICO
STRATEGIC DIRECTION
KEY FACTS
Summary 30 Wyeth SA de CV: Key Facts
Summary 31 Wyeth SA de CV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 32 Wyeth SA de CV: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 33 Wyeth SA de CV: Competitive Position 2006
ANALGESICS IN MEXICO
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 12 Sales of Analgesics by Subsector: Value 2001-2006
Table 13 Sales of Analgesics by Subsector: % Value Growth 2001-2006
Table 14 Herbal vs Standard Topical Analgesics 2001/2006
Table 15 Analgesics Company Shares by Retail Value 2002-2006
Table 16 Analgesics Brand Shares by Retail Value 2003-2006
Table 17 Forecast Sales of Analgesics by Subsector: Value 2006-2011
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN MEXICO
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
Table 21 Sales of Decongestants by Type: Value 2001-2006
Table 22 Sales of Decongestants by Type: % Value Growth 2001-2006
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006
Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011
DIGESTIVE REMEDIES IN MEXICO
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 30 Sales of Digestive Remedies by Subsector: Value 2001-2006
Table 31 Sales of Digestive Remedies by Subsector: % Value Growth 2001-2006
Table 32 Herbal vs Standard Digestive Remedies 2001/2006
Table 33 Digestive Remedies Company Shares by Retail Value 2002-2006
Table 34 Digestive Remedies Brand Shares by Retail Value 2003-2006
Table 35 Forecast Sales of Digestive Remedies by Subsector: Value 2006-2011
Table 36 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2006-2011
MEDICATED SKIN CARE IN MEXICO
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 37 Sales of Medicated Skin Care by Subsector: Value 2001-2006
Table 38 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
Table 39 Herbal vs Standard Medicated Skin Care 2001/2006
Table 40 Medicated Skin Care Company Shares by Retail Value 2002-2006
Table 41 Medicated Skin Care Brand Shares by Retail Value 2003-2006
Table 42 Acne Treatments Brand Shares by Retail Value 2003-2006
Table 43 Hair Loss Treatments Brand Shares by Retail Value 2003-2006
Table 44 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
Table 45 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011
VITAMINS AND DIETARY SUPPLEMENTS IN MEXICO
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 46 Sales of Vitamins and Dietary Supplements by Subsector: Value 2001-2006
Table 47 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2001-2006
Table 48 Sales of Vitamins by Type: Value 2001-2006
Table 49 Sales of Vitamins by Type: % Value Growth 2001-2006
Table 50 Vitamins and Dietary Supplements Company Shares by Retail Value 2002-2006
Table 51 Vitamins and Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 52 Vitamins Brand Shares by Retail Value 2003-2006
Table 53 Sales of Dietary Supplements by Type: Value 2001-2006
Table 54 Sales of Dietary Supplements by Type: % Value Growth 2001-2006
Table 55 Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 56 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2006-2011
Table 57 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2006-2011
NRT SMOKING CESSATION AIDS IN MEXICO
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 58 Number of Smokers by Gender 2001-2006
SECTOR DATA
Table 59 Sales of Smoking Cessation Aids by Subsector: Value 2001-2006
Table 60 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2001-2006
Table 61 Smoking Cessation Aids Company Shares by Retail Value 2002-2006
Table 62 Smoking Cessation Aids Brand Shares by Retail Value 2003-2006
Table 63 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2006-2011
Table 64 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2006-2011
EYE CARE IN MEXICO
SECTOR DATA
Table 65 Sales of Eye Care by Subsector: Value 2001-2006
Table 66 Sales of Eye Care by Subsector: % Value Growth 2001-2006
Table 67 Eye Care Company Shares by Retail Value 2002-2006
Table 68 Eye Care Brand Shares by Retail Value 2003-2006
Table 69 Forecast Sales of Eye Care by Subsector: Value 2006-2011
Table 70 Forecast Sales of Eye Care by Subsector: % Value Growth 2006-2011
EAR CARE IN MEXICO
ADULT MOUTHCARE IN MEXICO
CALMING AND SLEEPING PRODUCTS IN MEXICO
WOUND TREATMENTS IN MEXICO
SECTOR DATA
Table 71 Sales of Wound Treatments by Subsector: Value 2001-2006
Table 72 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
Table 73 Wound Treatments Company Shares by Retail Value 2002-2006
Table 74 Wound Treatments Brand Shares by Retail Value 2003-2006
Table 75 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
Table 76 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011
EMERGENCY CONTRACEPTION IN MEXICO